Clinical Trials Directory

Trials / Conditions / Hepatitis C Genotype 1

Hepatitis C Genotype 1

5 registered clinical trials studyying Hepatitis C Genotype 1.

StatusTrialSponsorPhase
CompletedA Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infect
NCT02716428
Trek Therapeutics, PBCPhase 2
CompletedSafety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patie
NCT01471574
Bristol-Myers SquibbPhase 3
CompletedABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus I
NCT01464827
AbbVie (prior sponsor, Abbott)Phase 2
CompletedA Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With R
NCT01221298
AbbVie (prior sponsor, Abbott)Phase 2
CompletedA Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072
NCT01074008
AbbVie (prior sponsor, Abbott)Phase 2